文献速递造血干细胞移植与细胞治疗

支气管肺泡灌洗液在异基因造血干细胞移植后肺部并发症中的应用

[Application of bronchoalveolar lavage fluid in patients with pulmonary complications after allogeneic hematopoietic stem cell transplantation].
PubMed 文献 · Zhonghua Xue Ye Xue Za Zhi · 2019-01-01

该前瞻性研究纳入73例allo-HSCT患者共86例次肺部并发症、132例次BAL,BALF病因学诊断率为88.4%,感染性并发症占77.9%,以真菌感染为主;血小板低于50×10^9/L者BAL术中术后未发生严重出血,结论为BALF诊断价值高且安全。

要点

  • BALF对allo-HSCT后肺部并发症的病因学诊断率达88.4%。
  • 感染性并发症占77.9%,真菌感染最常见(33.7%)。
  • 血小板<50×10^9/L者行BAL未发生严重出血。

核心结论

  • 对allo-HSCT后肺部并发症患者,BALF病原体检测具有较高诊断价值且安全性良好。

研究设计与样本

  • 前瞻性研究纳入73例allo-HSCT患者,共86例次肺部并发症、132例次BAL。
  • BALF行微生物涂片/培养、CMV/EBV/结核DNA检测及mNGS病因学分析。

主要发现

  • BALF病因学诊断率为88.4%(76/86)。
  • 感染性并发症67例次(77.9%):真菌29例次(33.7%)、混合感染18例次(20.9%)、病毒11例次(12.8%)、细菌9例次(10.5%)。
  • 非感染性并发症9例次(10.5%):特发性肺炎综合征8例、淋巴瘤肺部浸润1例;10例次(11.6%)病因未明。
  • BAL前血小板<50×10^9/L的33例次术中术后均无严重出血;BAL后一过性发热10例次,其中4例次血培养为葡萄球菌,抗感染治疗有效,无其他严重并发症。

临床怎么用

  • 对allo-HSCT后出现肺部并发症的患者,可考虑行BAL获取BALF进行病原学检测以明确病因。
  • 血小板计数低于50×10^9/L并非BAL的绝对禁忌,本研究中未发生严重出血。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To evaluate the diagnostic value of bronchoalveolar lavage (BAL) for pulmonary complications in patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and its safety. Methods: Patients with pulmonary complications after allo-HSCT underwent BAL. Microbiological smears, culture, PCR of CMV-DNA, EBV-DNA and TB-DNA, macro genomes new generation sequencing (mNGS) techniques were performed to detect pathogens in BAL fluid (BALF) . Results: A total of 73 allo-HSCT patients with 86 times of pulmonary complications enrolled this prospective study. They underwent 132 times of BAL procedures. The clinical diagnoses of 88.4% cases were made based on BALF analysis. Of them, 67 cases (77.9%) had infectious pulmonary complications, including 29 cases (33.7%) of fungal infection, 18 cases (20.9%) of mixed infection, 11 cases (12.8%) of viral infection and 9 cases (10.5%) of bacterial infection. The other 9 cases (10.5%) of non-infectious pulmonary complications included 8 cases (9.3%) of idiopathic pneumonia syndrome (IPS) and 1 case (1.2%) of pulmonary infiltration of lymphoma. The diagnoses of the remaining 10 cases (11.6%) were not determined. The platelet counts of 33 patients were less than 50×10(9)/L before BAL. None of them developed severe bleeding complications during or after BAL. Transient fever occurred in 10 patients after BAL. Blood cultures showed staphylococcal bacteremia in them and anti-infection therapies were effective. No life-threatening complications occurred in all of the patients during or after BAL. Conclusion: BALF analysis was informative for the diagnosis of pulmonary complication and safe for patients with pulmonary complications after allo-HSCT. 目的: 评估支气管肺泡灌洗术(BAL)在异基因造血干细胞移植(allo-HSCT)患者肺部并发症中的诊断价值及安全性。 方法: 采用BAL获取肺泡灌洗液(BALF)进行微生物涂片/培养、巨细胞病毒/EB病毒及结核分枝杆菌DNA检测、宏基因组新一代测序对allo-HSCT后肺部并发症进行病因学分析。 结果: 纳入73例allo-HSCT患者,男47例,女26例,中位年龄41(15~64)岁。共发生86例次肺部并发症事件,进行132例次BAL。BALF检测病因学诊断率为88.4%(76/86)。感染性肺部并发症共67例次(77.9%),包括真菌感染29例次(33.7%)、混合感染18例次(20.9%)、病毒感染11例次(12.8%)、细菌感染9例次(10.5%)。非感染性肺部并发症共9例次(10.5%),包括特发性肺炎综合征8例、淋巴瘤肺部浸润1例。另有10例次未能明确病因(11.6%)。血小板计数低于50×10(9)/L的33例次BAL术中及术后均未发生严重出血,在BAL后一过性发热10例次,其中4例次血培养为葡萄球菌,抗感染治疗有效,无其他严重并发症。 结论: 对有肺部病变的allo-HSCT患者,BALF病原体检测具有较高的诊断价值,安全性良好。.

来源:Zhonghua Xue Ye Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Li S, Wan LP, Xie GG, et al. [Application of bronchoalveolar lavage fluid in patients with pulmonary complications after allogeneic hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 31775480. doi:10.3760/cma.j.issn.0253-2727.2019.10.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。